Status:

RECRUITING

Myocardial Dysfunction Evaluation in Lower Extremity Arterial Disease Patients With Deformation Analysis

Lead Sponsor:

Tartu University Hospital

Conditions:

Peripheral Artery Disease

Heart Failure

Eligibility:

All Genders

35-85 years

Brief Summary

Single centre observational study to assess lower extremity arterial disease (LEAD) patients' cardiac dysfunction with strain analyses and to assess connections between cardiac dysfunction, metabolomi...

Eligibility Criteria

Inclusion

  • Inclusion Criteria in LEAD group:
  • Fontaine I-IV class symptoms
  • Confirmed diagnosis of LEAD
  • Inclusion Criteria in control group:
  • Age 35-85
  • Has to have at least of the following: hypertension, diabetes, coronary artery disease or the patient smokes
  • Exclusion Criteria:
  • Age \<35 or \>85 years
  • BMI ≥40 kg/m²
  • Known heart failure in history
  • Any acute or chronic autoimmune or rheumatic disease
  • Cardiac structural disease in history: inflammatory, infiltrative diseases, nonischemic cardiomyopathies
  • Acute coronary syndrome in last 3 months
  • Moderate to severe cardiac valvular disease
  • Cardiac valvular disease operative/invasive treatment in history
  • Cardiac implantable electronic device (CIED)
  • Transitory ischemic attack or stroke in last 3 months
  • Severe COPD (GOLD C or D)
  • Moderate to severe asthma (according to GINA 2022 criteria)
  • Untreated hypertension (noninvasive blood pressure measurement ≥180/110 mmHg during recruitment)
  • Chronic severe kidney dysfunction (eGFR \<30 ml/min/1,73 m²)
  • Malignant tumor with radiation treatment to thorax, oncologic or biologic treatment in history
  • Chronic hematologic disease (except for anemia)
  • Severe liver dysfunction
  • Malignant tumor with \<5 years of remission
  • Acute or chronic infectious disease
  • Anemia with hemoglobin \<80 g/L

Exclusion

    Key Trial Info

    Start Date :

    February 1 2024

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2026

    Estimated Enrollment :

    162 Patients enrolled

    Trial Details

    Trial ID

    NCT06215248

    Start Date

    February 1 2024

    End Date

    December 31 2026

    Last Update

    December 16 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Tartu University Hospital

    Tartu, Estonia